E
Veru Inc. VERU
$0.4901 -$0.018-3.54%
Recommendation
Sell
Prev Close
$0.5081
Volume
1,109,292
Avg Vol (90D)
2,659,940
Market Cap
$74.38M
Dividend & Yield
--
52-Week Range
$0.45 - $1.92
P/E (TTM)
--
EPS (TTM)
-$0.2642
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
3/31/2025 - GuruFocus
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
3/31/2025 - Globe Newswire
Verus Capital Partners LLC Has $92.85 Million Holdings in Amazon.com, Inc. (NASDAQ:AMZN)
3/31/2025 - MarketBeat
Apple Inc. (NASDAQ:AAPL) Holdings Lowered by Verus Financial Partners Inc.
3/29/2025 - MarketBeat
Is Fathom Holdings Inc. (FTHM) the Cheapest Stock Insiders Are Buying In March?
3/28/2025 - Insider Monkey
Veru Sees Unusually High Options Volume (NASDAQ:VERU)
3/18/2025 - MarketBeat
Alphabet Inc. (NASDAQ:GOOGL) Stock Position Raised by Verus Capital Partners LLC
3/14/2025 - MarketBeat
Here's Why Veru (VERU) Looks Ripe for Bottom Fishing
3/12/2025 - Zacks Investment Research
Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround
3/6/2025 - Zacks Investment Research
Verus Capital Partners LLC Grows Holdings in Palo Alto Networks, Inc. (NASDAQ:PANW)
2/28/2025 - MarketBeat
Verus Capital Partners LLC Has $2.20 Million Holdings in PayPal Holdings, Inc. (NASDAQ:PYPL)
2/28/2025 - MarketBeat
Verus Capital Partners LLC Purchases 13,962 Shares of Palantir Technologies Inc. (NASDAQ:PLTR)
2/28/2025 - MarketBeat
Verus Capital Partners LLC Increases Position in Verizon Communications Inc. (NYSE:VZ)
2/28/2025 - MarketBeat
Invesco QQQ (NASDAQ:QQQ) Shares Bought by Verus Capital Partners LLC
2/28/2025 - MarketBeat
Verus Financial Partners Inc. Acquires New Holdings in NVIDIA Co. (NASDAQ:NVDA)
2/28/2025 - MarketBeat
Insider Buying: Veru Inc. (NASDAQ:VERU) Director Purchases 95,279 Shares of Stock
2/21/2025 - MarketBeat
Veru Inc. (NASDAQ:VERU) Director Michael L. Rankowitz Purchases 95,279 Shares
2/21/2025 - Ticker Report
Veru Inc. (NASDAQ:VERU) Director Michael L. Rankowitz Purchases 95,279 Shares
2/21/2025 - MarketBeat
COEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus ...
2/20/2025 - GuruFocus
Verus Wealth Management LLC Acquires New Shares in Amazon.com, Inc. (NASDAQ:AMZN)
2/19/2025 - MarketBeat
Veru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in January
2/16/2025 - MarketBeat
Veru (NASDAQ:VERU) Issues Earnings Results
2/14/2025 - MarketBeat
Veru (NASDAQ:VERU) Announces Quarterly Earnings Results
2/14/2025 - MarketBeat
Veru: Discussions on tariffs are negotiation means to an end
2/14/2025 - CNBC Television-YouTube
Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...
2/14/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$14.75M
EBITDA (TTM)
-$40.02M
EBIT (TTM)
-$40.28M
Net Income (TTM)
-$38.47M
Balance Sheet
Total Assets (Q)
$39.83M
Total Debt (Q)
$3.52M
Total Liabilities (Q)
$13.20M
Book Value Per Share (Q)
$0.1819
Cash Flow
Cash from Operations (TTM)
-$26.99M
Cash from Investing (TTM)
$17.39M
Cash from Financing (TTM)
-$4.37M
Net Change in Cash (TTM)
-$13.97M
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of April (est)
Price History
Loading...
Beta
2.26
7-Day Total Return
-2.91%
30-Day Total Return
-9.46%
60-Day Total Return
-24.66%
90-Day Total Return
-16.02%
Year to Date Total Return
-24.81%
1-Year Total Return
-35.51%
2-Year Total Return
-62.87%
3-Year Total Return
-90.54%
5-Year Total Return
-85.01%
52-week Low
Mar 14, 2025 - $0.45
52-week High
Apr 11, 2024 - $1.92
Valuation
Market Cap
$74.38M - Micro Cap
Enterprise Value
$51.69M
Price/Sales (TTM)
5.05
Price/Book (Q)
2.79
Dividends and Shares
Shares Outstanding
146.38M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
verupharma.com
Phone Number
305 509 6897
Address
2916 North Miami Avenue
Miami, FL 33127
Country
United States
Year Founded
1971
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome... more
NASDAQ 03/31/2025 4:00PM Eastern Quotes delayed
Weiss Ratings